• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Studi

  2026-04-30

  This study establishes a streamlined protocol for deriving intestinal organoids from human pluripotent stem cells, enabling more physiologically relevant pharmacokinetic assessments than traditional models. The organoids exhibit key functional properties, including active drug metabolism and transporter activity, enhancing the translational potential of in vitro assays for orally administered drugs.

• MLN2238: Precision Proteasome β5 Subunit Inhibition in Oncol

  2026-04-29

  MLN2238 is redefining proteasome β5 subunit inhibitor workflows with nanomolar potency, robust performance in bortezomib-resistant models, and unique engagement of the ROS/JNK/CREB stress axis. This article offers actionable protocol guidance, troubleshooting strategies, and insights bridging molecular mechanism to translational advances in myeloma and lymphoma research.

• Nicotine Signaling Accelerates Chronic Kidney Disease Progre

  2026-04-29

  This review synthesizes clinical and experimental evidence implicating nicotine, a key tobacco constituent, as a driver of chronic kidney disease (CKD) progression through activation of renal nicotinic acetylcholine receptors and induction of oxidative and fibrotic pathways. The findings highlight mechanistic links between smoking and worsening renal outcomes, underscoring the need for targeted research on mitigation strategies.

• CDK9 Inhibitor (A3294): Technical Use and Protocol Parameter

  2026-04-28

  CDK9 inhibitor (A3294) enables selective inhibition of cyclin dependent kinase 9 for studies of transcription elongation and HIV-1 propagation. It is not suited for pan-CDK inhibition or protocols necessitating prolonged working solution storage. Researchers should use this reagent where high selectivity and minimal cytotoxicity are critical.

• EGTA in Applied Calcium Signaling: Endothelial & Neuro Model

  2026-04-28

  EGTA (egtaizic acid) excels in dissecting calcium-mediated pathways in both endothelial inflammation and neuroprotection research. This guide details optimized workflows, real-world troubleshooting, and actionable protocol parameters, leveraging APExBIO's high-purity EGTA for robust, reproducible results.

• Methylprednisolone Sodium Succinate: Mechanistic and Strateg

  2026-04-27

  This thought-leadership article provides translational researchers with a mechanistic and strategic guide to leveraging Methylprednisolone Sodium Succinate (SKU B4953) in advanced inflammation and immunology studies. It contextualizes the compound’s nuclear receptor-driven biology, experimental performance metrics, and competitive advantages in both cellular and clinical research models, highlighting actionable protocols and forward-looking perspectives for accelerating anti-inflammatory drug development.

• Structural Insights into HCAR3 Agonist Selectivity via Cryo-

  2026-04-27

  Ye et al. (2025) elucidate the structural determinants of HCAR3 ligand recognition using cryo-EM, revealing the molecular basis for agonist selectivity between HCAR3 and HCAR2. These insights inform rational design of hypolipidemic agents with improved selectivity and reduced side effects.

• Tunicamycin: Precision N-Glycosylation Inhibitor for ER Stre

  2026-04-26

  Tunicamycin from APExBIO streamlines ER stress and glycosylation research with high solubility, reproducibility, and validated effects on inflammation and protein chaperone induction. Harness its power to dissect cell stress pathways, optimize macrophage assays, and model glycosylation-dependent tumorigenesis with data-backed confidence.

• Sodium Overload Impairs Mitochondrial Metabolism to Drive NE

  2026-04-25

  Qiao et al. (2025) reveal how sodium influx triggers catastrophic mitochondrial dysfunction, executing necrosis via the NECSO pathway. This mechanistic insight links TRPM4-mediated Na+ entry to energy failure and highlights mitochondrial membrane potential assays as critical investigative tools.

• Lypressin Acetate: Mechanistic Insight and Translational Str

  2026-04-24

  This thought-leadership article explores the mechanistic underpinnings and strategic potential of Lypressin acetate in translational research. By integrating evidence from peer-reviewed literature and cross-domain applications, it provides actionable guidance for researchers in endocrine, cardiovascular, and emerging antiviral fields. The piece uniquely bridges mechanistic pharmacology with translational context, outperforming standard product summaries by offering protocol guidance, competitive analysis, and an informed outlook.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-04-24

  Wang et al. (2024) uncover a METTL16-driven signaling axis that confers ferroptosis resistance and accelerates tumorigenesis in hepatocellular carcinoma (HCC). Their mechanistic work reveals new intervention targets for sensitizing HCC cells to ferroptosis, with translational implications for cancer research.

• E3 Gene Deletion Does Not Attenuate CAdV-2 Pathogenicity in

  2026-04-23

  This study characterized a novel canine adenovirus type 2 (CAdV-2) strain with a 9-nucleotide E3 gene deletion and compared its pathogenicity to wild-type isolates in experimental canine infections. Results revealed that the E3-deleted strain retained virulence, indicating functional redundancy in the E3 region and informing ongoing vaccine and surveillance strategies.

• MDL 28170: Precision Calpain Inhibition for Translational Im

  2026-04-23

  This thought-leadership article provides mechanistic and strategic insights into the use of MDL 28170, a selective calpain and cathepsin B inhibitor, for translational researchers tackling neuroprotection, ischemia-reperfusion injury, and beyond. Drawing on pivotal evidence, including recent Neuropharmacology findings on BDNF/TrkB signaling disruption, the piece offers actionable protocol guidance and competitive context. It advances the discourse by bridging rigorous mechanistic rationale with practical workflow recommendations, elevating the conversation beyond standard product summaries.

• Halazone: Antimicrobial Sulfonamide Derivative in Water and

  2026-04-22

  Halazone stands out as a dual-function antimicrobial sulfonamide derivative: a gold-standard water disinfection agent and a precise modulator of neuronal sodium channels in electrophysiology. This article delivers protocol-level guidance and troubleshooting tips for both microbiological and neurophysiological research, leveraging Halazone’s unique oxidative and membrane-modifying actions.

• Plant Exosome-like Nanovesicles Restore Sertoli Cell Functio

  2026-04-22

  This study reveals that exosome-like nanovesicles derived from Cistanche deserticola (CDELNs) significantly alleviate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. The work uncovers a novel, HSPG-mediated uptake mechanism and miRNA-driven pathway modulation, providing a foundation for innovative therapeutic strategies in male reproductive toxicity.

16590 records 1/1106 page Next 12345 下5页 Last page